Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN111196791B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111196791B reveals a novel Rh-catalyzed route to chiral gamma-butyrolactones with high enantioselectivity, offering cost-effective API intermediate solutions.